Vinyl laurate

produced by Wacker Chemie AG, Burghausen, Germany, ≥98.0% (GC)

Linear Formula:
CAS Number:
Molecular Weight:
Beilstein/REAXYS Number:
EC Number:
MDL number:
PubChem Substance ID:
Pricing and availability is not currently available.


produced by Wacker Chemie AG, Burghausen, Germany

Quality Level


≥98.0% (GC)


254 °C/1013 hPa (lit.)


H2O: slightly soluble 1 g/L at 20 °C


0.871 g/mL at 20 °C (lit.)

SMILES string




InChI key


Looking for similar products? Visit Product Comparison Guide

General description

Vinyl laurate is a clear, colorless to light yellow colored liquid. The flash point is 125°C. It forms aqueous colloidal microgel by copolymerization with N-isopropylacrylamide. The enzymatic acylation of Avicel cellulose with vinyl laurate, a solvent free reaction system, was studied.


Vinyl laurate was used in the synthesis of laurate and stearate esters of corn starch. It was used as the acyl donor during synthesis of sucrose laurate esters catalyzed by Bacillus pseudofirmus AL-89 . Vinyl laurate was also used in the preparation of chirally deuterated benzyl chlorides.


1 kg in glass bottle

Other Notes

prices for bulk quantities on request

Personal Protective Equipment

dust mask type N95 (US),Eyeshields,Gloves


NONH for all modes of transport

WGK Germany


Flash Point(F)

257.0 °F

Flash Point(C)

125 °C

Stavros Gremos et al.
Bioresource technology, 102(2), 1378-1382 (2010-10-05)
Cellulose esters are an important class of functional biopolymers with great interest in the chemical industry. In this work the enzymatic acylation of Avicel cellulose with vinyl propionate, vinyl laurate and vinyl stearate, has been performed successfully in a solvent...
Novel gelling behavior of poly (N-isopropylacrylamide-co-vinyl laurate) microgel dispersions.
Benee LS, et al.
Langmuir, 18(16), 6025-6030 (2002)
Sophie Cohen et al.
Journal of acquired immune deficiency syndromes (1999), 68(2), 178-185 (2014-11-19)
Immigrant HIV-infected adults in industrialized countries show a poorer clinical and virologic outcome compared with native patients. We aimed to investigate potential differences in clinical, immunological, and virologic outcome in Dutch HIV-infected children born in the Netherlands (NL) versus born...
Gabriele Spina et al.
IEEE journal of biomedical and health informatics, 19(5), 1567-1576 (2015-05-15)
With the growing amount of physical activity (PA) measures, the need for methods and algorithms that automatically analyze and interpret unannotated data increases. In this paper, PA is seen as a combination of multimodal constructs that can cooccur in different...
Hugues Charest et al.
PloS one, 9(10), e109420-e109420 (2014-10-09)
HIV drug resistance represents a major threat for effective treatment. We assessed the trends in the frequency of drug resistance mutations and the monitored viral load (VL) in treatment-naïve (TN) and treatment-experienced (TE) individuals infected with HIV-1 in Québec, Canada...

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.